Showing results (1-10 of 132) with videos related to
Sort By:
Pageof 14
Current Opinion in Molecular Therapeutics|August 11, 2001
Redirection of drug metabolism using antisense technologyV Arora, P L IversenDrug Metabolism and Disposition: the Biological Fate of Chemicals|January 21, 2000
Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivoV Arora, P L IversenBiochemical and Biophysical Research Communications|June 10, 1998
Manipulation of metallothionein expression in the regenerating rat liver using antisense oligonucleotidesV Arora, P L Iversen, M EbadiPharmaceutical Research|August 26, 1998
In vivo properties of an in situ forming gel for parenteral delivery of macromolecular drugsR Joshi, V Arora, J P Desjardins, et al.Current Opinion in Molecular Therapeutics|August 11, 2001
Phosphorodiamidate morpholino oligomers: favorable properties for sequence-specific gene inactivationP L IversenGeneral Pharmacology|November 1, 1994
Metallothionein in carcinogenesis and cancer chemotherapyM Ebadi, P L IversenAntisense & Nucleic Acid Drug Development|September 13, 2000
Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomersC Ghosh, P L IversenThe Journal of General Virology|October 1, 1989
Inhibition of human immunodeficiency virus type 1-mediated cytopathic effects by poly(L-lysine)-conjugated synthetic antisense oligodeoxyribonucleotidesM Stevenson, P L IversenBiological Signals|March 1, 1992
Antisense oligonucleotide-mediated inhibition of metallothionein protein synthesis in neuroblastoma IMR 32 and Chang liver cells in cultureP L Iversen, M EbadiThe Journal of Pharmacology and Experimental Therapeutics|February 25, 2000
c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activityV Arora, D C Knapp, B L Smith, et al.Pageof 14